Alice Beardmore-Gray
Overview
Explore the profile of Alice Beardmore-Gray including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
39
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kuhrt K, Mabula-Bwalya C, Boulding H, Beardmore-Gray A, Ridout A, Koroma O, et al.
BMC Glob Public Health
. 2025 Jan;
3(1):3.
PMID: 39773363
Pre-eclampsia is a leading cause of maternal and neonatal mortality; 30,000 pre-eclampsia-related maternal deaths occur annually, with 70% in Sub-Saharan Africa (SSA) and 16% in South Asia. We have shown...
2.
Beardmore-Gray A, Simwinga M, Vwalika B, Chinkoyo S, Chappell L, Sandall J, et al.
BMJ Open
. 2024 Apr;
14(4):e076744.
PMID: 38580359
Objective: Providing comprehensible information is essential to the process of valid informed consent. Recruitment materials designed by sponsoring institutions in English-speaking, high-income countries are commonly translated for use in global...
3.
Beardmore-Gray A, Vousden N, Seed P, Vwalika B, Chinkoyo S, Sichone V, et al.
Lancet
. 2023 Jul;
402(10399):386-396.
PMID: 37393919
Background: Pre-eclampsia is a leading cause of maternal and perinatal mortality. Evidence regarding interventions in a low-income or middle-income setting is scarce. We aimed to evaluate whether planned delivery between...
4.
Chappell L, Brocklehurst P, Green M, Hardy P, Hunter R, Beardmore-Gray A, et al.
Health Technol Assess
. 2022 Dec;
PMID: 36547875
Background: In women with late preterm pre-eclampsia (i.e. at 34 to 36 weeks' gestation), the optimal delivery time is unclear because limitation of maternal-fetal disease progression needs to be balanced...
5.
Hunter R, Beardmore-Gray A, Greenland M, Linsell L, Juszczak E, Hardy P, et al.
Pharmacoecon Open
. 2022 Jul;
6(5):723-733.
PMID: 35861912
Aim: There is currently limited evidence on the costs associated with late preterm pre-eclampsia beyond antenatal care and post-natal discharge from hospital. The aim of this analysis is to evaluate...
6.
Beardmore-Gray A, Seed P, Fleminger J, Zwertbroek E, Bernardes T, Mol B, et al.
Am J Obstet Gynecol
. 2022 Apr;
227(2):218-230.e8.
PMID: 35487323
Objective: Pregnancy hypertension is a leading cause of maternal and perinatal mortality and morbidity. Between 34 and 36 weeks gestation, it is uncertain whether planned delivery could reduce maternal complications...
7.
Beardmore-Gray A, Greenland M, Linsell L, Juszczak E, Hardy P, Placzek A, et al.
BJOG
. 2022 Apr;
129(10):1654-1663.
PMID: 35362666
Objective: We evaluated the best time to initiate delivery in late preterm pre-eclampsia in order to optimise long-term infant and maternal outcomes. Design: Parallel-group, non-masked, randomised controlled trial. Setting: Forty-six...
8.
Beardmore-Gray A, Vousden N, Silverio S, Charantimath U, Katageri G, Bellad M, et al.
Reprod Health
. 2021 Jun;
18(1):110.
PMID: 34078408
Background: Pre-eclampsia is a leading cause of maternal and perinatal mortality and morbidity globally. Planned delivery between 34 and 36 weeks may reduce adverse pregnancy outcomes but is yet to...
9.
Beardmore-Gray A, Vousden N, Charantimath U, Katageri G, Bellad M, Kapembwa K, et al.
Trials
. 2020 Nov;
21(1):960.
PMID: 33228794
Background: Pre-eclampsia is a pregnancy complication characterised by high blood pressure and multi-organ dysfunction in the mother. It is a leading contributor to maternal and perinatal mortality, with 99% of...
10.
Warner R, Beardmore-Gray A, Pakzad M, Hamid R, Ockrim J, Greenwell T
Int Urogynecol J
. 2019 Jul;
31(7):1363-1369.
PMID: 31321464
Introduction And Hypothesis: The objective was to assess the comparative provider costs of vaginal and open abdominal repair of vesicovaginal fistula (VVF) and to determine the most cost-effective means of...